J. Huggins

发表

Transancestral mapping and genetic load in systemic lupus erythematosus

P. Gregersen, J. Rioux, P. Gaffney, 2017, Nature Communications.

Validation of the Cutaneous Lupus Erythematosus Disease Area and Severity Index and pSkindex27 for use in childhood-onset systemic lupus erythematosus

S. Ozen, H. Brunner, J. Huggins, 2018, Lupus Science & Medicine.

Maintaining Hepatitis B Protection in Immunocompromised Pediatric Rheumatology and Inflammatory Bowel Disease Patients

E. Smitherman, L. Danziger-Isakov, J. Huggins, 2020, The Journal of Rheumatology.

Initial Benchmarking of the Quality of Medical Care in Childhood‐Onset Systemic Lupus Erythematosus

M. Klein-Gitelman, H. Brunner, J. Huggins, 2016, Arthritis care & research.

International Consensus for Provisions of Quality‐Driven Care in Childhood‐Onset Systemic Lupus Erythematosus

M. Klein-Gitelman, M. Punaro, M. Beresford, 2013, Arthritis care & research.

Pediatric SLE—towards a comprehensive management plan

M. Klein-Gitelman, H. Brunner, J. Huggins, 2011, Nature Reviews Rheumatology.

Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis

M. Elder, E. Ramsay, C. Sandborg, 2021, Pediatric Rheumatology.

polyclonal rabbit antithymocyte globulin Apoptosis and complement-mediated lysis of myeloma cells by

M. Zand, J. Liesveld, C. Abboud, 2013 .

Measuring Disease Damage and Its Severity in Childhood‐Onset Systemic Lupus Erythematosus

B. Feldman, B. Goilav, M. Beresford, 2018, Arthritis care & research.

Organ involvement other than lupus nephritis in childhood-onset systemic lupus erythematosus

H. Brunner, J. Huggins, M. Holland, 2016, Lupus.

Allergen immunotherapy.

J. Huggins, R. Looney, 2004, American family physician.

Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry

C. Sandborg, R. Schneider, R. Sundel, 2022, Pediatric Rheumatology.

Targeting B cells in the treatment of childhood-onset systemic lupus erythematosus.

H. Brunner, J. Huggins, 2006, The Journal of pediatrics.

Use of intravenous immunoglobulin G (IVIG).

J. Huggins, R. Looney, 2006, Best practice & research. Clinical haematology.

Polyclonal Rabbit Antithymocyte Globulin Triggers B-Cell and Plasma Cell Apoptosis by Multiple Pathways

M. Zand, Benjamin J. Briggs, J. Liesveld, 2005, Transplantation.

A plausibly causal functional lupus-associated risk variant in the STAT1–STAT4 locus

Daniel E. Miller, P. Gaffney, M. Weirauch, 2018, Human molecular genetics.

Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin.

J. Huggins, R. Looney, A. Coca, 2009, Clinical immunology.

Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease: Characterization and Risk Factors

B. Trapnell, K. Wikenheiser-Brokamp, H. Brunner, 2019, Arthritis & rheumatology.

Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin.

M. Zand, J. Liesveld, C. Abboud, 2006, Blood.

Validation of the Pediatric Automated Neuropsychological Assessment Metrics in childhood‐onset systemic lupus erythematosus

D. Beebe, H. Brunner, J. Huggins, 2013, Arthritis care & research.

Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis

C. Correll, C. Sandborg, S. Goodman, 2022, Pediatric rheumatology online journal.

Improving a process to obtain hepatitis B serology among patients treated with infliximab at a large urban children’s hospital

E. Smitherman, L. Denson, L. Danziger-Isakov, 2017, BMJ open quality.

A134: Validation of Patient Reported Outomes Measurement Information System Modules for use in Childhood‐;onset Lupus

J. Huggins, J. Ying, Jiha Lee, 2014 .

Adolescent Vaccination Strategies: Interventions to Increase Coverage

C. Lehmann, J. Huggins, R. Brady, 2016, Pediatric Drugs.

Self-management and adherence in childhood-onset systemic lupus erythematosus: what are we missing?

A. Modi, J. Huggins, L. Crosby, 2019, Lupus.

CpG DNA activation and plasma-cell differentiation of CD27- naive human B cells.

M. Zand, E. Milner, I. Sanz, 2007, Blood.

Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Non-Infectious, Chronic Anterior Uveitis.

A. Cassedy, H. Brunner, J. Huggins, 2022, American journal of ophthalmology.

Usefulness of Cellular Text Messaging for Improving Adherence Among Adolescents and Young Adults with Systemic Lupus Erythematosus

D. Drotar, H. Brunner, J. Huggins, 2012, The Journal of Rheumatology.

The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis

H. Brunner, J. Huggins, D. Lovell, 2020, Pediatric Rheumatology.

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy

D. Foell, Bin Huang, J. Verbsky, 2019, Arthritis & rheumatology.

Polyarticular Arthritis and Skin Nodulosis in a 14‐Year‐Old Female

R. Mcmasters, H. Brunner, J. Huggins, 2016, Arthritis care & research.

Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans

C. Sandborg, R. Schneider, R. Sundel, 2021, Arthritis & Rheumatology.

Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease

Bin Huang, J. Verbsky, L. Wagner-Weiner, 2018, Arthritis & rheumatology.

Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry

C. Sandborg, L. McAllister, Y. Zhang, 2021, Pediatric Rheumatology.

Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE

H. Brunner, J. Huggins, Chen Chen, 2023, Lupus Science and Medicine.

AB1065 THE UTILISATION OF S100 PROTEINS TESTING IN PEDIATRIC RHEUMATOLOGY PATIENTS IN A TERTIARY CARE INSTITUTION AND IMPLICATIONS FOR CARE

H. Brunner, J. Huggins, M. Henrickson, 2019, Abstracts Accepted for Publication.

Feasibility and acceptability of an innovative adherence intervention for young adults with childhood-onset systemic Lupus Erythematosus

A. Modi, J. Huggins, L. Crosby, 2020, Pediatric Rheumatology.

Childhood‐Onset Lupus Nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short‐Term Kidney Status and Variation in Care

J. Fennell, C. Sandborg, R. Sundel, 2022, Arthritis care & research.

Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study

G. Tomlinson, C. Sandborg, L. McAllister, 2021, Arthritis & rheumatology.

Childhood‐Onset Lupus Nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short‐Term Kidney Status and Variation in Care

J. Fennell, C. Sandborg, R. Sundel, 2022, Arthritis care & research.

Disease course, treatments, and outcomes of children with systemic juvenile idiopathic arthritis associated lung disease (SJIA-LD).

Alex V. Pickering, M. Stoll, A. Hersh, 2023, Arthritis care & research.

Allergen immunotherapy.

J. Huggins, R. Looney, 2004, American family physician.